ARL4C and ovarian cancer: It has also been demonstrated that the overexpression of ARL4C was detected in about 60% (25 out of 41) of OCCC cases, and that ARL4C predicted a poor prognosis in endometriosis-associated ovarian cancers, including OCCC [32].